Rinvoq® (upadacitinib)
for Arthritis Rheumatoid

Rinvoq (upadacitinib) is an oral Janus kinase (JAK) inhibitor used to treat inflammatory conditions like rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, ulcerative colitis, and Crohn's disease. It works by blocking the Janus kinase enzyme to reduce immune system activity and control inflammation. Rinvoq can be used alone or with other medications.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Arthritis Rheumatoid